Program · Outcome 1: Minimised impacts of cancer, including through national leadership in cancer control with targeted research and clinical trials; evidence informed clinical practice; strengthened national data capacity; community and consumer information and support
Program 1.1: Improved Cancer Control
Provide national leadership in cancer control across the care continuum to reduce the impact of cancer, address disparities, and improve outcomes for people affected by cancer through the development and promotion of evidence-based practice, funding cancer research, and providing consumers and health professionals with cancer information and resources.
Cancer Australia, 2026-27 Portfolio Budget Statements, PDF page 11 reported
$50m
2026-27 Budget estimate
−$1.3m (−2.5%) on 2025-26 estimated actual
Traced to named suppliers and grant recipients
AusTender and GrantConnect record the agency, not the program, so contracts and grants are shown on the entity page.
Published lines
Each row is one line of the program’s expense table in the 2026-27 Portfolio Budget Statements – Program Expense Line Items, as published.
| Line | Kind | 2025-26 estimated actual |
2026-27 Budget estimate |
Change | Treatment | Source |
|---|---|---|---|---|---|---|
| Ordinary annual services | administered | $34m | $35m | +$254k +0.7% | reported | 2.1.1 NCCE Prog Exp, row 647 |
| Departmental appropriation | departmental | $17m | $16m | −$1.0m −6.2% | reported | 2.1.1 NCCE Prog Exp, row 648 |
| Expenses not requiring appropriation in the Budget year | departmental | $210k | $206k | −$4k −1.9% | reported | 2.1.1 NCCE Prog Exp, row 649 |
| Operating deficit (surplus) | departmental | $500k | $0 | −$500k −100.0% | reported | 2.1.1 NCCE Prog Exp, row 646 |